Neurogene Inc. Share

Neurogene Inc. (NGNE) is a United States-based biotechnology company focused on developing genetic medicines for neurological diseases. The company is dedicated to addressing the unmet needs of patients and families affected by rare and devastating neurological disorders. Neurogene utilizes advanced gene therapy platforms to deliver potentially transformative treatments directly to the central nervous system. Their research and development efforts are centered on developing novel therapies that target the underlying genetic causes of these conditions, with the goal of improving patient outcomes and quality of life. Neurogene operates within the biotechnology sector, specifically focusing on gene therapy and neurological disease treatment.